Tarsus Accounts Payable from 2010 to 2024

TARS Stock  USD 48.24  1.84  3.97%   
Tarsus Pharmaceuticals Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount Tarsus Pharmaceuticals owes to suppliers or vendors for products or services received but not yet paid for. It represents Tarsus Pharmaceuticals' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-09-30
Previous Quarter
26.7 M
Current Value
26.8 M
Quarterly Volatility
8.1 M
 
Covid
Check Tarsus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 6.8 M or Depreciation And Amortization of 529.3 K, as well as many indicators such as Price To Sales Ratio of 35.81, Dividend Yield of 0.0 or PTB Ratio of 3.17. Tarsus financial statements analysis is a perfect complement when working with Tarsus Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tarsus Pharmaceuticals Correlation against competitors.
For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Latest Tarsus Pharmaceuticals' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Tarsus Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents Tarsus Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Tarsus Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Tarsus Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Tarsus Accounts Payable Regression Statistics

Arithmetic Mean3,321,830
Geometric Mean624,293
Coefficient Of Variation192.24
Mean Deviation4,365,061
Median175,000
Standard Deviation6,385,747
Sample Variance40.8T
Range18.9M
R-Value0.71
Mean Square Error21.7T
R-Squared0.50
Significance0
Slope1,014,647
Total Sum of Squares570.9T

Tarsus Accounts Payable History

202419.1 M
202318.1 M
20225.5 M
20212.9 M
20202.2 M
2019456 K

About Tarsus Pharmaceuticals Financial Statements

Tarsus Pharmaceuticals shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tarsus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tarsus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable18.1 M19.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tarsus Stock Analysis

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.